US equities |
SPCX $166.73 ▲+4.89% NVDA $236.76 ▲+1.20% MU $1,063.40 ▼-1.07% TSLA $376.97 ▲+1.72% MSFT $524.18 ▲+1.28% SNDK $1,705.68 ▼-0.83% INTC $117.39 ▼-1.63% META $742.43 ▲+1.97%
FinancialContent

Articles published by UroGen

News headline image
UroGen Announces FDA Advisory Committee for UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
From UroGen
Via Business Wire
Tickers URGN